These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33705865)

  • 1. Identification of filovirus entry inhibitors targeting the endosomal receptor NPC1 binding site.
    Wang LL; Palermo N; Estrada L; Thompson C; Patten JJ; Anantpadma M; Davey RA; Xiang SH
    Antiviral Res; 2021 May; 189():105059. PubMed ID: 33705865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A biaryl sulfonamide derivative as a novel inhibitor of filovirus infection.
    Isono M; Furuyama W; Kuroda M; Kondoh T; Igarashi M; Kajihara M; Yoshida R; Manzoor R; Okuya K; Miyamoto H; Feldmann H; Marzi A; Sakaitani M; Nanbo A; Takada A
    Antiviral Res; 2020 Nov; 183():104932. PubMed ID: 32946918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-based design of peptide entry inhibitors targeting the endosomal receptor binding site of filoviruses.
    Wang LL; Estrada L; Wiggins J; Anantpadma M; Patten JJ; Davey RA; Xiang SH
    Antiviral Res; 2022 Oct; 206():105399. PubMed ID: 36007601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two Distinct Lysosomal Targeting Strategies Afford Trojan Horse Antibodies With Pan-Filovirus Activity.
    Wirchnianski AS; Wec AZ; Nyakatura EK; Herbert AS; Slough MM; Kuehne AI; Mittler E; Jangra RK; Teruya J; Dye JM; Lai JR; Chandran K
    Front Immunol; 2021; 12():729851. PubMed ID: 34721393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Virion-Based Assay for Glycoprotein Thermostability Reveals Key Determinants of Filovirus Entry and Its Inhibition.
    Bortz RH; Wong AC; Grodus MG; Recht HS; Pulanco MC; Lasso G; Anthony SJ; Mittler E; Jangra RK; Chandran K
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32611759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Insights into the Interaction of Filovirus Glycoproteins with the Endosomal Receptor Niemann-Pick C1: A Computational Study.
    Igarashi M; Hirokawa T; Takadate Y; Takada A
    Viruses; 2021 May; 13(5):. PubMed ID: 34069246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Filoviruses Use the HOPS Complex and UVRAG To Traffic to Niemann-Pick C1 Compartments during Viral Entry.
    Bo Y; Qiu S; Mulloy RP; Côté M
    J Virol; 2020 Jul; 94(16):. PubMed ID: 32493822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Filovirus entry: a novelty in the viral fusion world.
    Hunt CL; Lennemann NJ; Maury W
    Viruses; 2012 Feb; 4(2):258-75. PubMed ID: 22470835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct Intracellular Visualization of Ebola Virus-Receptor Interaction by
    Mittler E; Alkutkar T; Jangra RK; Chandran K
    mBio; 2021 Jan; 12(1):. PubMed ID: 33436438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies.
    Bornholdt ZA; Ndungo E; Fusco ML; Bale S; Flyak AI; Crowe JE; Chandran K; Saphire EO
    mBio; 2016 Feb; 7(1):e02154-15. PubMed ID: 26908579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.
    Cheng H; Lear-Rooney CM; Johansen L; Varhegyi E; Chen ZW; Olinger GG; Rong L
    J Virol; 2015 Oct; 89(19):9932-8. PubMed ID: 26202243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoterpenoid-based inhibitors of filoviruses targeting the glycoprotein-mediated entry process.
    Sokolova AS; Yarovaya OI; Zybkina AV; Mordvinova ED; Shcherbakova NS; Zaykovskaya AV; Baev DS; Tolstikova TG; Shcherbakov DN; Pyankov OV; Maksyutov RA; Salakhutdinov NF
    Eur J Med Chem; 2020 Dec; 207():112726. PubMed ID: 32905862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between TIM-1 and NPC1 Is Important for Cellular Entry of Ebola Virus.
    Kuroda M; Fujikura D; Nanbo A; Marzi A; Noyori O; Kajihara M; Maruyama J; Matsuno K; Miyamoto H; Yoshida R; Feldmann H; Takada A
    J Virol; 2015 Jun; 89(12):6481-93. PubMed ID: 25855742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential pharmacological strategies targeting the Niemann-Pick C1 receptor and Ebola virus glycoprotein interaction.
    Morales-Tenorio M; Ginex T; Cuesta-Geijo MÁ; Campillo NE; Muñoz-Fontela C; Alonso C; Delgado R; Gil C
    Eur J Med Chem; 2021 Nov; 223():113654. PubMed ID: 34175537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential inhibitors of protein-protein interaction useful to fight against Ebola and other highly pathogenic viruses.
    Lasala F; García-Rubia A; Requena C; Galindo I; Cuesta-Geijo MA; García-Dorival I; Bueno P; Labiod N; Luczkowiak J; Martinez A; Campillo NE; Alonso C; Delgado R; Gil C
    Antiviral Res; 2021 Feb; 186():105011. PubMed ID: 33428961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1.
    Carette JE; Raaben M; Wong AC; Herbert AS; Obernosterer G; Mulherkar N; Kuehne AI; Kranzusch PJ; Griffin AM; Ruthel G; Dal Cin P; Dye JM; Whelan SP; Chandran K; Brummelkamp TR
    Nature; 2011 Aug; 477(7364):340-3. PubMed ID: 21866103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of coumarine derivatives as potent anti-filovirus entry inhibitors targeting viral glycoprotein.
    Gao Y; Cheng H; Khan S; Xiao G; Rong L; Bai C
    Eur J Med Chem; 2020 Oct; 204():112595. PubMed ID: 32707357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ebola virus entry requires the host-programmed recognition of an intracellular receptor.
    Miller EH; Obernosterer G; Raaben M; Herbert AS; Deffieu MS; Krishnan A; Ndungo E; Sandesara RG; Carette JE; Kuehne AI; Ruthel G; Pfeffer SR; Dye JM; Whelan SP; Brummelkamp TR; Chandran K
    EMBO J; 2012 Apr; 31(8):1947-60. PubMed ID: 22395071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A limited structural modification results in a significantly more efficacious diazachrysene-based filovirus inhibitor.
    Selaković Z; Opsenica D; Eaton B; Retterer C; Bavari S; Burnett JC; Solaja BA; Panchal RG
    Viruses; 2012 Aug; 4(8):1279-88. PubMed ID: 23012625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a small-molecule entry inhibitor for filoviruses.
    Basu A; Li B; Mills DM; Panchal RG; Cardinale SC; Butler MM; Peet NP; Majgier-Baranowska H; Williams JD; Patel I; Moir DT; Bavari S; Ray R; Farzan MR; Rong L; Bowlin TL
    J Virol; 2011 Apr; 85(7):3106-19. PubMed ID: 21270170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.